SynAgile's Private Equity Round

SynAgile raised a round of funding on August 24, 2017. Investors include East Peak Capital.

SynAgile is developing DopaFuse, designed to be the first patient-friendly, noninvasive therapy for continuous delivery of L-DOPA and carbidopa. The medication is delivered from a small, comfortable d…

Articles about SynAgile's Private Equity Round: